Tablets & Capsules

TC0520

Issue link: https://www.e-digitaleditions.com/i/1244583

Contents of this Issue

Navigation

Page 14 of 43

Tablets & Capsules May 2020 13 8. www.businessimageprinting.com/avoiding-costly- packaging-mistakes-of-cbd-products/ Neil Main is global market development manager for phar- maceutical high-barrier packaging films and Lauryn Over- bey is a territory sales manager at ACG (908 757 3425, www.acg-world.com). Peter J. Schmitt is managing director of Montesino, a global packaging consulting and research firm (302 888 2355, www.montesino. com). ACG Group's comprehensive new blockchain-based brand security system simplifies the track-and-trace process and overcomes several longstanding obstacles t o a d v a n c e d t ra c e a b il it y t h r o u gh distributed- ledger technology and single ownership to provide a seamless, trans- parent user experience. there is optimism that distribution will expand into super- markets and mass retailers. In fact, the United Kingdom Food Standards Agency recently issued a positive ruling on CBD, which the FDA is likely to consider in its own decision making [4, 5]. Recently, FDA commissioner Stephen Hahn stated that the agency will continue to "take appropriate action against unlawful CBD products that pose a risk of harm to the public" but offered no timeline for when the agency might release guidelines [6]. Commissioner Hahn vowed that the FDA will "monitor the marketplace" and punish sellers who make unsub- stantiated claims about the benefits of CBD, but he also said that the agency would not take any extra steps to stop consumers from getting over-the- counter CBD [7]. Considering the level of FDA atten- tion focused on the cannabis industry, a cautious approach to manufactur- ing and distributing CBD products is wise. The key to success is following industry guidelines and standards and partnering with experts, so that, when retailers begin to show interest, your products are market ready and already meet the standards. Select a packaging supplier who has industry compli- ance experience, is up to date on industry standards, and can provide brand guidance. A company with marketing expertise will take into account the requirements of your target market and can help you create an effective prod- uct design, which is not always an easy task [8]. This may include assisting with color combinations and brand con- sistency to ensure that your packaging is compliant with state and local laws. In the new and somewhat uncharted territory of the CBD market, following NACB guidelines and working with a knowledgeable manufacturing, packaging, and solutions partner will put you on the best path. T&C References 1. "Global cannabis packaging market, Forecast to 2025," Orian Research, www.orianresearch.com. 2. www.nacb.com/national-standards-packaging 3. www.nacb.com/national-lab-testing-product- integrity-standards 4. www.food.gov.uk/business-guidance/cannabidiol-cbd 5. hempindustrydaily.com/uncertain-future-for-cbd- continued-competition-drive-down-cv-sciences-4th- quarter-sales/ 6. www.fda.gov/news-events/press-announcements/fda- advances-work-related-cannabidiol-products-focus- protecting-public-health-providing-market 7. www.marijuanamoment.net/banning-cbd-products- would-be-a-fools-game-fda-chief-admits/ Considering the level of FDA attention focused on the cannabis industry, a cautious approach to manufacturing and distributing CBD products is wise.

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0520